Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial

Fig. 2

Overlap of patients identified as being of high risk by conventional prognostic factors, gene expression-based risk scores or proliferation, and metascores. Venn diagrams showing overlap of patients identified as being of high risk by a gene expression-based risk scores or proliferation, i.e., GEP70, IFM15 scores, and GPI, as well as HM metascore and b GEP70, IFM15 scores, GPI, and rISS. See Table 1 for details and further prognostic factors. rISS, International Staging System; GPI, gene expression-based proliferation index

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us